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ABSTRACT
THE IMPACT OF COLLABORATIVE BEHAVIORAL HEALTH ON TREATMENT
OUTCOMES OF DIABETES
by

Adam Johnson, Master of Science
Utah State University, 2019
Major Professor: Dr. Dave Robinson
Department: Human Development and Family Studies
In this study, I hypothesized that patients who utilized collaborative care, involving both
medical and behavioral health providers, will decrease overall medical utilization when
compared to a control group of patients receiving only standard medical treatment. I also
hypothesized that patients who utilized collaborative care will experience a greater increase in
overall health comparatively. Although previous research has shown collaborative medical and
behavioral health treatments to be effective in improving health outcomes for patients who have
a chronic illness. I found no significant difference in the improvements in health outcomes
(A1c) made by my treatment group who received psychosocial intervention in addition to
standard medical treatment for diabetes management when compared to my control group who
received only medical treatment. I did find that collaborative treatment was associated with
increases in medical utilization as were increases in age and initial A1c levels. Clinical
implications include the need for therapists to remember that BPSS intervention should be used
in collaboration with medical treatment rather than in place of and they should be aware of how
biological factors, such as age and severity of symptoms, may affect psychosocial-spiritual
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factors commonly addressed in therapy when working with patients who have chronic illnesses
like diabetes.
(48 pages)

v

PUBLIC ABSTRACT
THE IMPACT OF COLLABORATIVE BEHAVIORAL HEALTH ON TREATMENT
OUTCOMES OF DIABETES

Adam Johnson
A current body of research is finding significant connection between biological,
psychological, social, and spiritual factors in health and wellbeing. Some studies have found
significant improvements in treatment outcomes for patients who received medical treatment in
collaboration with psychosocial therapeutic treatment. In this study, I sought to observe the
impact collaborative treatment had on patients with diabetes who were treated at a community
health center. I compared the treatment outcomes of a group of patients who received a
collaborative treatment, looking to see if their overall health (measured by A1c, a diabetes
severity marker) and medical utilization (or their number of doctors’ visits).
I found no significant difference in the improvements in health outcomes (A1c) made by
my treatment group who received collaborative treatment in addition to standard medical
treatment for diabetes management when compared to my control group who received only
medical treatment. I did find that collaborative treatment was associated with increases in
medical utilization as were increases in age and initial A1c levels. Clinical implications include
the need for therapists to be aware of how biological factors, such as age and severity of
symptoms, may affect psychosocial-spiritual factors commonly addressed in therapy when
working with patients who have chronic illnesses like diabetes. I hope that these findings will
lead future research into the association of collaboration and medical utilization in order to find
if there are any clinical benefits to recommending increased utilization for patients who are older
or begin treatment with higher A1c levels.
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CHAPTER I
INTRODUCTION
In response to an increase in awareness of interconnected biopsychosocial-spiritual
(BPSS) factors (Engle, 1977; Hodgson, Lamson, Mendenhall, & Crane, 2014), collaborative
treatment addressing BPSS factors is being recommended more and more frequently
(Sivapalasingam et al., 2014). Current research has shown that collaborative care, where
therapeutic treatment of psychological, interpersonal, and spiritual issues is integrated into
medical treatment of chronic health conditions, can provide clinicians with better treatment
outcomes (Lustman & Clouse, 2002), patients with more positive health care experiences
(Hodgson, McCammon, Marlowe, & Anderson, 2012), insurance companies with cheaper costs
(Crane, Christenson, Dobbs, Schaalje, Moore, Pedal, & Marshall, 2013), and administrators with
a more efficient medical system (Hodgson et al., 2014). Not only could collaborative treatment
improve over health for more people, but better health and strong family relationships can
significantly improve individual’s quality of life (Cundiff, Birmingham, Uchino, & Smith, 2016).
My goal in this study is to examine the effect collaborative health care, that addresses
BPSS needs holistically, can have on medical outcomes for patients being treated for diabetes.
Previous research has already shown that psychotherapy for comorbid mental health concerns,
like depression, can improve coping and influence the course of medical conditions (Sledge &
Gold, 2010). Other findings have found that supportive social relationships can prevent
contraction of disease, ease the course of symptoms, and even speed up the recovery process
following illness or injury (Broadbent & Koschwanez, 2012). With this study, I hope draw from
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clinical data gathered over five years in an integrated community health center where medical
providers work in collaboration with behavioral health providers who are trained to address
BPSS factors, potentially allowing us to improve both the comorbid psychological as well as the
connected social and spiritual issues in treatment of patients with diabetes. I hope to help
address the gap in research, identified by Lustman and Clouse (2002), who called for, “long-term
studies that examine the effects of depression treatment on the eventual expression of the
complications of diabetes.” Results will be discussed for their implications in clinical
application and future directions for research.
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CHAPTER II
LITERATURE REVIEW

Introduction
Often patients with chronic illness, such as diabetes or cardiovascular disease, also suffer
from a related mental health condition, commonly depression and anxiety (Lustman & Clouse,
2002). Moreover, their family relationships may be struggling as well due to increased stress
associated with caregiver responsibilities or the threat of losing an ill family member. To
provide a more comprehensive form of treatment for patients suffering from chronic illness, it’s
important for behavioral health providers to address the biological, psychological, and social
needs of their clients. This can improve the client’s overall sense of well-being and quality of
life, which can then positively influence the outcomes of their condition (Engle, 1977).
As I seek to see if comprehensive treatment can improve treatment outcomes for
biological, psychological, and social problems, I will review the current literature surrounding
the use of Engel’s holistic biopsychosocial model (1977), examining how each factor- biological,
psychological, and social- influence each other. I will then address the problematic split in the
current healthcare system between medical and mental health services and explore the literature
supporting Medical Family Therapy (MedFT) as a strong comprehensive treatment model to
bridge that split. Finally, I will outline how this study will add to current research by comparing
longitudinal samples of patients who received collaborative therapy, which addressed
psychological, social, and spiritual issues in addition to standard medical treatment of diabetes. I
hope to further support the claim that treatment approaches, which comprehensively address
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biological, psychological, social, and spiritual factors improve treatment outcomes and overall
health for the patient.

The Biopsychosocial Model
In 1977, Engel proposed a new model to help in diagnosing increasingly interactive
mental, medical and social problems. He called it the biopsychosocial model (Engle,
1977). Emphasizing the fact that reductionistically looking for a single source of a problem
limits treatment outcomes and fails to treat other aspects of well-being that might be influencing
patients’ illness. Assessing for factors from the different areas of a patient’s life collectively
allows treatment to reach to biological aspects such as physical health and medical conditions,
psychological aspects like mental disorders or positive thinking, and social aspects revolving
around relationships with family and friends. Years later, a 4 th aspect was added considering the
impact of a patient’s spirituality, which includes factors such as meaning-making, values and
beliefs, and even religious influences (Wright, Watson, & Bell, 1996).

The biopsychosocial-

spiritual (BPSS) model is used to holistically improve all aspects of a patient’s life that may be
contributing to their current condition (Engle, 1977). This model has been fundamental for
integrated fields such as health psychology and medical family therapy.
One new area of research, which highlights the interconnectedness of the BPSS model, is
psychoneuroimmunology. Psychoneuroimmunology is used to examine the relationships
between psychological and social factors and disease or health, and their impact on the immune
system (Byrne-Davis, & Vedhara, 2008). Experts look to see if strong family or social
relationships and positive thinking can help make a person physically more resilient in
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preventing and recovering from injury or disease. These claims are strongly supported by the
current research in the field (Broadbent & Koschwanez, 2012).

Impact of Social factors on Biological and Psychological Functioning
There are multiple social factors that play a role in physical and psychological
functioning. Family functioning can have an incredible impact, both positive and negative, on
mental and physical health. Social factors like economic hardship, inability to make connections
with peers, cultural demands can lead to higher levels of stress, weakening the immune system
(McDade, 2001). Distress in marriage and family relationships can lead to higher levels of
depression and anxiety (Russo, Coker, & King, 2017). Divorce has been associated with
damaging impacts on achievement, self-esteem, and physical well-being for children as well as
their parents (Zeratsion et al., 2015).
While negative relationships can take their toll on a person’s psychological, biological,
and social functioning, they can have an equally positive effect when relationships are strong
(Jaremka, Lindgren, & Kiecolt-Glaser, 2013). Strong social support has been linked to better
psychological functioning and improved physical recovery following injuries (Broadbent &
Koschwanez, 2012). A happy marriage is another common factor in health outcomes such as
longevity (Kaplan & Kronick, 2006), prevention of chronic illness (Cundiff et al., 2016) and
mental illness (Deklyen, Brooks-Gunn, McLanahan, & Knab, 2006). In fact, marriage quality
has been identified as a key factor in later life well-being and quality of life appraisals (Carr,
Freedman, Corman, & Schwarz, 2014). People who remain in unhappy marriages are more
prone to higher distress, significantly lower reported feelings of happiness, life satisfaction, selfesteem, and overall health (Hawkins & Booth, 2005). Theoretically, I argue that interventions
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targeting family and social relationships could improve psychological and biological functioning
as well.

Impact of Psychological Factors on Biological and Social Functioning
Psychological factors like stress and depression consistently influence biological systems,
leading to symptoms like reduction of antibodies in the immune system, increasing a person’s
exposure to illness (Jaremka et al., 2013). For example, stress induced inflammation may be a
key reaction linking distress to poor health and is a risk factor in cardiovascular diseases, type 2
diabetes, metabolic syndrome, and frailty (Jaremka et al., 2013). Positive psychology, on the
other hand, can lead to a greater resiliency in immunity and better health, a point emphasized in
psychoneuroimmunology (Byrne-Daves & Vedhara, 2008).
Psychological interventions seeking to improve mental functioning have been connected
to positive biomedical outcomes across several different chronic illnesses (Irwin,
2008). Psychotherapy was successful in improving the conditions of irritable bowel syndrome in
66% of studied patients, ages 16-60 (Creed et al., 2003). Additionally, disturbances in sleep and
social life, general distress, and coping with work and marriage were also improved in these
subjects, leading to higher quality of life. There are examples also of cognitive-behavioral
therapy (CBT) being implemented simultaneously with standard hospital treatments having
significantly decreasing patients’ bodily complaints because of better insight into the
psychosomatic causes of their pain (Ehlert, Wagner, & Lupke, 1999). One may argue that these
results are due to the presence of somatoform disorders, but the point is that psychological and
medical health are deeply intertwined. This fact is reinforced by studies showing the
bidirectional effects of medical and psychological interventions in treatment for individuals with
schizophrenia (Briand et al., 2006). It is likely that in treating one aspect, you will improve the
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other as well (Engle, 1977). Collaborating treatment between medical providers and mental
health providers could capitalize on biopsychosocial-spiritual interplay and improve both
medical and psychological treatment outcomes for patients.
As far as psychological impact on families goes, DSM-5 and family systems (Russo et
al., 2017) examines case studies for each of DSM-5 diagnoses, highlighting how a mental illness
affects everyone in a family system, not just the diagnosed individual. Some examples include
spouses having to shoulder the brunt of parental caregiving responsibilities while their partner
struggles during a major depressive episode, or families experiencing increased anxiety due to
the unpredictable nature of a manic episode for an individual with bipolar disorder. When
seeking to treat families, it is essential to examine all aspects that may be factoring into the
presenting problem.

Impact of Biological Factors on Psychological and Social Functioning
While some biological factors such as sleep, diet and exercise have all be linked to
positive mental and social outcomes (Sarris, O’Neil, Coulson, Schweitzer, & Berk, 2014), I will
focus primarily on the impact that chronic medical conditions such as diabetes can have on
individuals psychological and relational well-being. Medical conditions can have direct impact
on mental and social functioning of an individual (DSM-V, 2013). Often, medical and mental
issues will have a comorbid, or coexisting, relationship, in which they simultaneously worsen
each other (Sprah, Dernovsek, Wahlbeck, & Haaramo, 2017). Neglecting to address this
connection between mind and body in treatment, could cause psychotherapy and medical
procedures to be less effective, providing few benefits to patients and possible leading to higher
rates of relapse (Sprah et al., 2017).
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For families, a new diagnosis of a medical condition can lead to enormous changes in the
lives of the individual diagnosed as well as their family members. The adaptations required to
accommodate a family member who is diagnosed with cancer, for example, can monopolize
many resources available to the family as treatments begin to take priority over jobs, vacations,
socializing, family events, and needs of other family members. Harrington, Kimball, & Bean
(2009) suggested that families dealing specifically with childhood cancer become part of a
distinct culture surrounding the illness. That and the anxiety of possibly losing a loved one can
significantly and even permanently change family relationships (Harrington et al., 2009).
Sellers (2000) emphasized the importance of an integrated care model to address
psychological and relational effects of cancer and cancer treatment on patients and loved
ones. Medical family therapists (MedFTs) have specific training in family relationships and the
effects of restructured relationships in response to traumatic experiences (Paris & Dankoski,
2011). Thus, relieving the burden of other team members and enhancing the patient’s care
experience by addressing the family become essential contributions by a MedFT to the treatment
process (Harrington et al., 2009).

Interconnectedness of All Health Domains
and the Additional Consideration of Spiritual
For a long time, research has tried to piece apart biological, psychological, and social
influences on patient's health to identify, isolate, and repair problematic symptoms and their
causes (McDaniel, Hepworth, & Doherty, 2014). An important part of the BPSS model is the
understanding that biological, psychological, social, and spiritual factors do not operate in
isolation, but rather are intimately intertwined and continually influence each other (Engle, 1977;
McDaniel et al., 2014).
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Wright and colleagues (1996) encouraged the addition of the spiritual component of the
BPSS model to help providers account for the complex experience patients have with their health
and illness across all these domains, and to address how family beliefs can impact treatment
outcomes. Spiritual beliefs can increase resiliency and provide a framework for families to make
meaning of illness and death but can also hinder patients from pursuing treatments that might be
at odds with personal values (Hodgson et al., 2014). Although I will focus less on spiritual
factors through the methods and discussion of this study due to the fact that I had no data
measuring spiritual influences, I would like to note that spirituality has been identified as a
critical component of patients’ and families’ health care and well-being (Chapman &
Grossoehme, 2002; Fogg, Flannelly, Weaver, & Handzo, 2004), and that patients often bring up
spiritual concerns as they try to navigate the complex interactions of BPSS factors during
treatment (Hodgson et al., 2014).

Problematic Separation of Mental, Medical, and Family Health Services
For much of the history of modern medicine, the medical field has focused on the human
body and how disease can be accounted for by deviations from the norm of measurable
biological (or somatic) variables (Engel, 1977). This has been very effective in understanding
and treating physical disease. Meanwhile, the field of psychology has focused more on human
development and how mental disorders can be diagnosed by deviations from the norm of
behavioral measures (Engel, 1977). In the last half a century, however, the two sciences have
been growing closer together due to advances in neurobiology and other sciences that have
explored the interactive nature of the mind and body (Bayer, Beale, & Viamontes, 2009) and
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evidence of this interconnected relationship has prompted both the medical and mental health
fields to begin integrating their patient care (Hodgson et al., 2014).
Attempts to consider biological, psychological, and social aspects of illness collectively,
and to provide comprehensive treatment can be seen in the training of medical practitioners to
assess for mental illnesses. This is often accomplished by the implementation of mental health
screening instruments in medical health clinics for patients and their supporting families.
Medical providers who have been trained to recognize mental health aspects of illness have been
successful in providing brief interventions to patients in their clinics (Brodaty & Andrews,
1983). For example, the diagnosis and inclusion of behavioral health specialists in treatment of
somatoform disorders has also saved time and effort in medical settings (Kojima, 2006). What’s
more, the addition of mental health screening instruments like the PHQ-9 and GAD-7 (Palmer &
Coyne, 2003), have increased awareness of depression and anxiety, which have been found to
impact patient recover, and helped practitioners provide more comprehensive treatment that
addresses all of the patient’s needs (Dooley, 2013). Some mental health providers, as
encouraged by the BPSS model, have made adjustments to include their patient’s physicians in
treatment plans, and I hope to continue to see this become standard practice (McDaniel et al.,
2014).
As discussed earlier, research has shown that psychotherapy focused on improving
psychological and social functioning can have a positive effect on the outcomes of treatments for
medical conditions (Sledge, 2010). However, because of the current split in the healthcare
system of the United States, receiving treatments for multiple different health conditions often
means visiting multiple providers for different treatments at different offices (Hodgson et al.,
2014). Because of the legal complexities of sharing confidential information between healthcare
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providers, information is often incomplete or not shared at all. This leads to uninformed
treatment that can take too long to deliver and which is possibly redundant, inaccurate, and not
cost efficient. In fact, Berenson and Burton (2011) found that one in seven hospitalized
Medicare patients had a healthcare error due to lack of communication, and one in five patients
were released, only to be readmitted within 30 days. This inefficient care drives medical costs
up while failing to provide long term solutions to the patients and creates a need for an integrated
healthcare system that provides a full range of collaborative health services to meet patients need
in a competent way.

Potential for Medical Family Therapy to Bridge the Gap Between Two Fields
In 1992, in an attempt to connect biological, psychological, and social factors in
treatment, Susan McDaniel, Jeri Hepworth, and William Doherty introduced a new field called
Medical Family Therapy (MedFT) as a way to provide comprehensive treatment to individuals
and families dealing with medical problems (McDaniel et al., 2014). Basing their approach in
the BPSS model, they began to seek connections between physical and mental illness and to
address illness from a systemic, or family oriented, standpoint. The field of MedFT places a
large emphasis on the benefits of collaboration between medical and mental health providers and
seeks to train MedFT’s on how to bridge the gap between the two fields (Pais & Dankoski,
2011).
Marlowe and colleagues (2012) suggested a framework of integrated primary care (IPC)
that would maximize a MedFT’s or other behavioral health professionals (BHP’s) efforts in a
primary care setting and minimize the impact of healthcare errors due to lack of
communication. They suggested a five-step process: (a) BHP gathers an initial understanding of
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patient’s case from medical records, (b) introduces themselves to the patient and addressing their
role as part of the medical team, purpose of the psychosocial assessment, and that their
involvement did not mean that there was bad news to report, (c) elicits the illness story using a
BPSS framework, (d) begins intervention, commonly using brief problem solving/supportive
therapy, psychoeducation and/or behavioral education, or referring the patient for additional
services, and then (e) relays the information received back to the medical provider to inform
holistic treatment of the patient’s needs. A trained MedFT’s position in medical centers could
also resolve issues caused by the legal complexities of sharing client treatment information
between separate clinics.
While collaborating between the medical and mental health fields is the important,
distinctive quality of MedFT, the focus on the family system is still its central purpose. Early on,
Doherty, McDaniel, & Hepworth (1994) reemphasized this fact when he pointed out that just as
we often distinguish between ‘medical illness’ and ‘psychological illness,’ we also separate both
issues from family problems. They said, “As practical as these distinctions may be for everyday
discourse, they only represent ways that I ‘punctuate’ the seamless web of human life” (pg.
12). At times this has been misunderstood to imply that family patterns cause disease, but what
is actually emphasized is the interactive nature of biopsychosocial-spiritual problems whereby
family patterns and disease mutually maintain each other (Wood et al., 1989).
As MedFTs maintain their family-oriented focus in medical and behavioral health clinics,
they will be able to address presenting problems in a more comprehensive way. As evidenced by
the amount of current research surrounding the family regarding the effects of relationships on
health and well-being, family focused preventative measures and interventions have the potential
to be incredibly beneficial to patients in their treatment outcomes.
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Application of MedFT in Treatment of Diabetes
Diabetes, type 2, is one chronic illness that gets a lot of attention from researchers
looking at BPSS impacts of diabetes, and potential benefits to wholistic treatment of BPSS
factors on diabetes management (Lustman & Clouse, 2002). Diabetes has been estimated to cost
$282,937 (Seuring, Archangelidi, & Suhrcke, 2015) over one lifetime, and can accelerate the
presentation of conditions such as coronary heart disease, potentially shortening patient life span
(Lustman & Clouse, 2002). Diabetes is also often associated with increased symptoms of
depression (Novak et al., 2017a) and spousal distress (Trump et al., 2018). The impact diabetes
can have across every aspect of a patient’s life serves as a great example of how the BPSS model
can help improve many aspects of patient well-being, and potentially provide more lasting
improvements in biological outcomes.
Stress is commonly examined as a moderating factor in diabetes management, stressors
such as disease specific stress (Anderson et al., 2016), economic stress from increased medical
expenses and decreased productivity as a result of diabetes (Novak et al., 2017b), marital stress
(Trump et al., 2018), and everyday life stress (Anderson et al., 2016). Personality traits and
depressive symptoms have been found to moderate patients ability to cope with the increased
stress associated with managing diabetes (Novak et al., 2017a), but partner support has been
found to affect patients’ stress (Trump et al., 2018), depression (Novak et al., 2017a), treatment
adherence (Anderson et al., 2016), and long term well-being (Crane et al., 2013). This implies
that treatment of social, psychological, and spiritual factors concurrently with medical treatment
of biological diabetes factors could be a more effective mode of treatment, a proposal which my
study seeks to corroborate.

14

The Purpose of This Study
The purpose of my study was to examine the impact biopsychosocial-spiritually oriented
interventions can have on medical treatment outcomes of diabetes, reinforcing the claim that in
treating one aspect of general health you can simultaneously improve other aspects as well, as
emphasized by the BPSS model (Engel, 1977). Lustman and Clouse (2002) found that
psychotherapy treating comorbid depression improved medical treatment outcomes for diabetes,
as measured by biomedical markers such as hemoglobin A1c (A1C). However, they stated that
treatment approaches that consistently improve depression and diabetes measures have not yet
been discovered (Lustman & Clouse, 2002).
In addition to improving biological health markers, findings from
psychoneuroimmunological research indicate that improved family relationships may help
sustain the healing in medical and mental illnesses following treatment (Broadbent &
Koschwanez, 2012). What’s more, Crane and colleagues (2013) identified family therapy was
the most cost-efficient modality of psychotherapy in treatment of depression, reducing levels of
depression in fewer sessions and decreasing rates of recidivism for patients. Reduced medical
utilization could benefit both patients and healthcare systems financially (Seuring et al., 2015)
These two points led to our second hypothesis that collaborative care would also decrease
medical utilization by patients who sought therapy as part of treatment for their diabetes and
comorbid depression.
I proposed that the holistic approach to treatment used in medical family therapy, in
coordination with standard medical treatments, could be effective at improving biological
outcomes health outcomes in treatment of diabetes, as well as decreasing utilization. From a
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BPSS perspective, behavioral health providers, such as MedFT’s, who are trained to collaborate
with medical providers in addressing biological, psychological, and social factors interactively
could address comorbid issues that affect physical health such as depression (Lustman & Clouse,
2002), family caregiving (Sivapalasingam et al., 2014), or beliefs about medication compliance
(Dooley, 2013).
Research Hypotheses
1. When compared to a control group of patients receiving only standard medical treatment,
I hypothesize that patients who utilized collaborative care, involving both medical and
behavioral health providers, will decrease overall medical utilization.
2. When compared to a control group of patients receiving only standard medical treatment,
I hypothesize that patients who utilized collaborative care will experience a greater
increase in overall health.
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CHAPTER III
METHODS
In this study, I analyzed existing data as part of routine clinical appointments at a
community health center. The health center provides healthcare services from physicians, nurse
practitioners, physician assistants, behavioral health therapists, dentists, and pharmacists. The
data were gathered as part of routine medical and therapy appointments by utilizing preexisting
measures. Using this data, I identified a sample of patients who sought therapy in addition to
their standard medical treatment for diabetes. Comparing this group to a control group of
patients only receiving medical treatment, I looked to see if collaborative healthcare, addressing
BPSS issues together, led to improvements in their physical health and medical utilization.

Procedures
Licensed behavioral health providers and graduate level interns under clinical supervision
offer therapy in collaboration with medical treatments to patients at a medical health
center. Their placement allowed them to address the patients’ medical conditions along with
additional psychological disorders or family problems that either resulted from, led to, or
exacerbated their medical problems. Using the BPSS model, these behavioral health providers
sought to comprehensively address these factors as part of the treatment the patients receive at
the medical center.
Like a procedure used by Delgadillo and his associates (2017), my data were gathered as
part of routine clinical care over the past 5 years at a community health center. Retrospective
clinical case records for a cohort of patients receiving family therapy were analyzed. My
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study was conducted using fully de-identified data, and therefore did not require informed
consent from the participants. Demographical information included the total number of
encounters patients had, age, gender, ethnicity, health plan, provider, and marital status. I
excluded records with no baseline or post treatment data, or records with only one therapy visits
or which were seen only as part of a behavioral health consult.

Sample
Table 1
Interval Descriptives
Demographic
Age
Encounters (per 6 months)
A1C Oldest
A1C Most Recent

Group

N

Mean

SD

Range

1
2
1
2
1
2
1
2

60
29
60
29
59
29
60
29

55.5
47.5
2.53
4.34
7.54
8.30
7.09
7.88

10.6
14.2
1.62
2.31
1.79
2.75
1.57
2.10

53.0
55.0
10.5
9.24
8.90
8.90
7.70
7.80

Table 2
Categorical Descriptives
Demographic
Race
White
African American
Asian
Native American
Pacific Islander
Multiple Races
Declined
Sex
Male
Female
Marital Status
Single

Group 1 (n = 60) Group 2 (n = 29)
N Percentage N Percentage
49
0
0
2
0
6
3

82
0
0
3
0
10
5

20
1
1
2
1
2
2

69
3
3
7
3
7
7

26
34

43
57

13
16

45
55

12

20

12

41

18
Married
35
Divorced
11
Widowed
2
Declined
0
Health Plan
Medicaid/Medicare
9
Privately Insured
33
Private Pay
2
Financial Assistance
Slide 1 (Below National Poverty Line) 11
Slide 2 (133% National Poverty Line)
2
Slide 3 (150% National Poverty Line)
1
Slide 4 (200% National Poverty Line)
1
Note. Due to rounding, totals may not equal 100.

58
18
3
0

14
1
1
1

48
3
3
3

15
55
3

4
13
0

14
45
0

18
3
2
2

9
1
2
0

31
3
7
0

Case records were divided into two groups – a treatment and control group. My
treatment group was gathered using a combination of codes for family therapy, psychological
conditions, and chronic medical conditions. Patients diagnosed with diabetes who were also
seen by behavioral health providers in the clinic were included in the sample. A control
group was then formed from data provided by the records of patients who were treated for
diabetes but never sought therapy in collaboration to their standard medical treatment, so I can
compare the rates of improvement in physical health.
Over 3000 patients were reported to have received treatment for diabetes in this
community health center over the past 4 years, of which sixty subjects were randomly selected
for my control group. Only 58 patients were reported to have been treated for diabetes and
accessed behavioral health intervention over the past 4 years. Of that group, 29 subjects met the
inclusion criteria for my treatment group and were included in the sample. Those who were only
seen for Screening, Brief Intervention, and Referral for Treatment (SBIRT), or case management
were not included in the sample because they did not receive family oriented collaborative
therapy. Only seven subjects were excluded due to their receiving therapy unrelated to their
diagnosis of diabetes or relational issues, as indicated by their lack of a social component of the
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goals, interventions, or structure of therapy. Another nine subjects were excluded because they
had no measures of A1C.
The control group (n = 60) was made up of 34 females and 26 males. In my control
group, 35 were married, 12 were single, 11 were divorced, and two were widowed. Ages ranged
from 22-75 years (M = 55, SD = 10.6). Of the control group, 81.67% were Caucasian, 3% were
Native American, 10% declared being multiple races, and 10% refused to report their race.
The treatment group (n = 29) was made up of 16 females and 13 males. In my treatment
group, 14 were married, 12 were single, 1 was divorced, one was widowed, and one refused to
share. Ages ranged from 20-75 years (M = 47.5, SD = 14.2). Of the treatment group, 69% were
Caucasian, 3% were African American, 3% were Asian, 7% were Native American, 3% Pacific
Islander, 7% declared being multiple races, and 7% refused to report their race (see Table 2).

Measures
Hypothesis 1
In this study, I limited medical utilization to include problem visits and follow-up visits
with medical providers, as well as nurses’ visits. Auto-prescribing encounters and routine checkups were not included in the measurement, as we hope that such encounters would remain
consistent as part of good health maintenance, regardless of whether patients received certain
medical or behavioral health intervention. Behavioral health visits were also excluded from our
medical utilization measurement, as we are looking to see what effect collaborative therapy will
have on medical outcomes.
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Hypothesis 2
I used medical markers, specifically Hemoglobin A1c (A1c) lab results, to track the
course of diabetes management in both the treatment group and the control group to compare
treatment outcomes for the course of the conditions. A1c is a test measuring average glucose
levels over a 3-month period. A1c levels range from 4%-5.6% for people without diabetes, 5.76.4% means someone is at higher risk for diabetes, and levels over 6.5% means someone has
diabetes. In the community health center where my data was collected, A1c results lower
than 7% were considered “in compliance,” meaning patients were managing their diabetes well.
I used markers of A1c levels at two time points, the oldest lab on patient records and the most
recent. As data was gathered during routine clinical visits, A1c levels were taken on different
dates for different patients. This pre-post marker allowed us to account for change that happened
during the duration of treatment at my clinic.

Data Analysis
Hypothesis 1
The goals of the analyses were to determine whether collaborative healthcare had a
significant effect on treatment outcomes of diabetes. For my first research question
I ran a Poisson regression analysis to see if the utilization of medical services decreased
during collaborative treatment. For the purposes of this study, medical utilization was defined as
a problem visit or follow up visit with the primary medical provider or a nurse visit. Routine
immunizations, lab draws, and automatic prescription refills were not counted.
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Hypothesis 2
In order to compare the multiple variables, I observed for the second research question, I
first ran independent t-tests to see if there were differences between the control and treatment
groups at either pre- or post-treatment. I then computed a repeated measures ANOVA to see if
there any difference in the rate of change between the groups from pre- and post-treatment.
Finally, I utilized a multiple regression analysis to examine how my two groups changed
between pre- and post-treatment two while controlling for other variables. I first wanted to know
if the change of my treatment group was significantly different than the control in indicators of
diabetes management (A1c). I then ran more specific comparison analyses within the multiple
regression model, looking at significant associations between other possible moderating
factors and outcomes for my treatment and control groups.
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CHAPTER IV
RESULTS
First, using a Poisson generalized linear model, I identify variables that were associated
with significant changes in overall medical utilization. Results will be discussed in depth in the
following section. Next, results of the calculated multiple linear model are outlined, addressing
how well my grouping variable predicted post-treatment HgA1c.

Hypothesis 1
A Possion generalized linear model was used to find significant associations between
variables and medical utilization counts. The control group had significantly lower medical
utilization (p < .001) on average (M = 2.53, SD = 1.62) than did the treatment group (M = 4.34,
SD = 2.31). Patients in the treatment group (group = 2) were 55.7% more likely to have
additional visits for every 6-month period (exp(B) = 1.557, p < .001). Additionally, married and
divorced subjects were significantly more likely to visit the doctor than single members of my
sample (married exp(B) = 1.292, p = .007, divorced exp(B) = 2.981, p < .001), and males were
more likely than female patients (exp(B) = 1.079, p = .042). Age was also significantly
associated, with subjects (exp(B) = 1.010, p < .001) being 1% more likely to have more visits for
each additional year in age. Initial A1c count was also significantly associated with increases in
medical utilization (exp(B) = 1.030, p < .001) with subjects having 3% more doctor visits every
6 months for every 1 unit increase in initial A1c.
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Hypothesis 2
Independent sample t tests were calculated as a preliminary analysis to ensure equality
between the two groups. I found no significant difference, so I know I have equality between the
groups. A repeated measures ANOVA was then calculated to measure changes in A1c scores for
both groups. A significant decrease in A1c levels from time 1 to time 2 was found for both
groups as a whole (F = 4.84, p = .03), indicating that treatment at the community health center
was successful in helping patients move towards compliance in their diabetes management
regardless if they received additional collaborative behavioral health services. However,
differences between the control and treatment groups at pre- (control: M = 7.54, SD = 1.79,
treatment: M = 8.30, SD = 2.31, p = .121), and post-treatment (control: M = 7.09, SD = 1.57,
treatment: M = 7.88, SD = 2.10, p = .051), and in the rate of change (F = 1.11, p = .997) indicate
that there was not a significant difference in outcomes for patients who received collaborative
medical and psychosocial treatment.
A multiple linear regression was calculated to predict end A1c levels based on beginning
A1c levels and case grouping. Model results showed that treatment group was not a significant
predictor (b = .0718, p = .840, β = .0190). A1c level pretreatment was a significant predictor of
A1c levels post-treatment, where each unit increase in A1c beginning scores was associated with
lower ending levels of A1c (b = -.5092, p < .001, β = -.6180) while controlling other variables.
Other factors such as age, sex, marital status, and health plan were not found to have significant
associations with final A1c levels.
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CHAPTER V
DISCUSSION
Hypothesis 1
Interestingly, patients in my treatment group had significantly higher medical utilization,
the inverse of what I had thought would be the case. Generally, higher medical utilization
accompanies increased costs, and as past research, such as Crane et al. (2013), found family
therapy to be the most cost efficient psychotherapeutic treatment for conditions such as
depression, further research should seek to replicate this result and explore the possible benefits
of increased utilization that may be associated with collaborative healthcare which would make
higher cost of treatment worth it. Outcomes such as improved quality of life, patients feeling
more involved or informed in treatment, higher patient satisfaction with treatment, and increased
resilience or relapse prevention (Crane et al., 2013) should be considered in future efforts to
explain the moderating effect of collaborative care on medical utilization.
This study also found that age, gender, and severity of pretreatment A1c, were associated
with significant increases in medical utilization. Surprisingly, men in this sample were more
likely to visit the doctor than women, a finding which contradicts much of the research regarding
gender and medical utilization (Han et al., 2018; Koo, Madden, & Maguen, 2015; Ting et al.,
2017). However, this was the case for both the control and experimental group, implying that
this may be the result of a particular demographic rather than collaborative intervention.
Increases in age are frequently found to be associated with increases in medical
utilization (Fergus, Griggs, Cunningham, & Kelley, 2017; Han et al., 2018; Roquet et al., 2018).
In this study, I did not look to see specifically how collaborative healthcare affected different age
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groups, however, in future studies I hope to explore how addressing psychosocial-spiritual issues
related to aging (Emanuel, Bennett, & Richardson, 2007) might impact medical utilization as
well as other health outcomes, seeing as this study corroborated the finding that older patients
access healthcare more frequently than younger ones do.
Regarding severity of pretreatment A1c leading to increased utilization, it is possible that
medical providers encourage patients with poorer health hygiene habits or treatment compliance
to seek collaborative behavioral health intervention to address issues that are preventing them
from managing their diabetes (Clark, Linville, & Rosen, 2009). Future studies should enquire
the degree to which collaborative therapists encourage increased medical utilization, either for
psychotropic medication consultations or increased involvement in or compliance with treatment
recommendations from physicians.
Hypothesis 2
In this study, I did not find significant improvements of measures of A1c nor significant
decreases in medical utilization like I hypothesized in my treatment group of patients who went
to therapy for psychosocial treatment in collaboration with their standard medical treatments. It
is important to note that patients with higher pretreatment A1c tended to have lower posttreatment A1c than other patients, indicating that there may be a table effect in diabetes
management, where once A1c levels have been brought to manageable levels, it is more difficult
to see significant decreases regardless of the type of intervention. In the future, I plan to see if
collaborative healthcare significantly improved treatment outcomes, specifically for patients who
started above the threshold of compliance in management of their diabetes.
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Clinical Implications
Due to the similar change in medical outcomes for patients with diabetes in my control
and treatment group, I am unable at this time to add my voice to that of other researchers
(Sivapalasingam et al., 2014), providing support for the inclusion of collaborative health care in
treatment of diabetes based on my study. However, with the results of this study showing a
significant decrease in A1c for both groups, I would like advocate for the efficacy of current
medical treatments of diabetes and remind collaborative health care providers that therapeutic
intervention addressing psychological, social, and spiritual factors has been shown to be
beneficial in collaboration with, and not in place of, medical treatment (Marlowe et al., 2012).
Additionally, therapists should be aware of how biological factors, such as age and severity of
symptoms, may affect psychosocial-spiritual factors commonly addressed in therapy when
working with patients who have chronic illnesses like diabetes.

Limitations
Most of this sample was white, heterosexual, married patients, which inhibits my ability
to generalize these findings to all populations. My treatment group sample size (n = 29) was
inadequately powered to assess the differences in treatment outcomes between my control and
treatment groups. While I was able to find enough subjects that met the criteria of my control
group to pool a randomized sample, I did not randomize my treatment group, instead using all 29
subjects that met the inclusion criteria. This does less to control for confounding variables in my
sampling, which can be one of the problems associated with using existing data. I hope to
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collaborate with other community health centers to continue adding to my sample, and wonder if
a replication of my study with an adequate sample size would find similar or different results.
Furthermore, because my data were gathered as part of clinical visits, the time intervals
between data points and especially between patients varied greatly. I had hoped to be able to use
more psychological measures, such as anxiety assessments (GAD-7), and more biological
measures such as current glucose levels in addition to the 3-month averages shown by A1c tests,
but the data gathered in the clinic on other measures was too inconsistent to be useful. I had
also wanted to include more chronic health conditions than just diabetes, such as hypertension,
but were unable to gather a sample of patients who met my inclusion criteria. The fact that
behavioral health providers were able to address biopsychosocial issues in collaboration with
medical providers was an incredible strength to my study. However, because the data were
gathered from retroactive records, I was not able to control for therapist style or competency.
Using retroactive data to quickly form a longitudinal study was an incredible strength for
my study, but it did limit us in the amount of control I had over potential confounding variables.
Only clinically relevant data were gathered as part of treatment, such as A1c and PHQ-9 scores,
limiting my ability to control for compounding life factors that may have affected health
outcomes such as work stress, family crisis, or unexpected lifestyle changes. For example,
patients began and ended treatment at different points throughout the 5 year span of my clinical
observation, but because I observed their health using a retroactive study, I was unable to inquire
why they began or ended treatment, whether that was because they moved to a new community,
their insurance changed, they were referred elsewhere, or any number of confounding
circumstances that happen as part of everyday life.
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Lastly, I made some procedural decisions, such as inclusion and exclusion criteria, based
on available data and clinical practicality. Should I use a larger research team in future
extensions of this study, these decisions might be different.

Future Directions
A prospective study where goals and parameters were established before gathering a
sample and beginning to track data could have given us more control over the confounding
variables that affected my study. Future studies which identify a sample population that could
benefit from collaborative biopsychosocial intervention and proactively tracking treatment
outcomes longitudinally throughout treatment could increase my ability to observe more
variables that may be influencing health outcomes and provide more consistently tracked time
points, making it easier to analyze and find associations later on. For example, I could begin to
ask why patients in my treatment group increased their medical utilization and begin looking for
ways to study that trend.
As part of this study, I also gathered data including psychological measurements and
characteristics of therapeutic treatment such as length and style that I hope to be able to use to
answer further research questions looking for more specific interactions between biopsychosocial
factors beyond just overall treatment outcomes in A1c levels for patients who were also treated
for diagnoses of depression. Additionally, it may be possible to look more closely at the changes
in my control and treatment group using all the longitudinal data points I have using a multi-level
statistical model. Doing so would also allow me to look more closely at the interactions between
treatment outcomes and demographic variables such as age and pretreatment severity of A1c.
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Conclusion
Although previous research has shown collaborative medical and behavioral health
treatments to be effective in improving health outcomes for patients who have a chronic illness
(Delgadillo et al., 2017; Lustman & Clouse, 2002), probably due to my limited sample size, I
found no significant difference in the improvements in health outcomes (A1c) made by my
treatment group who received psychosocial intervention in addition to standard medical
treatment for diabetes management when compared to my control group who received only
medical treatment. I did find that collaborative treatment was associated with increases in
medical utilization as were increases in age and initial A1c levels. I hope that these findings will
lead future research into the association of collaboration and medical utilization in order to find
if there are any clinical benefits to recommending increased utilization for patients who are older
or begin treatment with higher A1c levels.
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